Literature DB >> 2683072

Normal expression of a rearranged and mutated c-myc oncogene after transfection into fibroblasts.

A Richman1, A Hayday.   

Abstract

Expression of the c-myc oncogene is deregulated in a variety of malignancies. Rearrangement and mutation of the c-myc locus is a characteristic feature of human Burkitt's lymphoma. Whether deregulation is solely a result of mutation of c-myc or whether it is influenced by the transformed B cell context has not been determined. A translocated and mutated allele of c-myc was stably transfected into fibroblasts. The rearranged allele was expressed indistinguishably from a normal c-myc gene: it had serum-regulated expression, was transcribed with normal promoter preference, and was strongly attenuated. Thus mutations by themselves are insufficient to deregulate c-myc transcription.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2683072     DOI: 10.1126/science.2683072

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  LR1 regulates c-myc transcription in B-cell lymphomas.

Authors:  A Brys; N Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

2.  Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters.

Authors:  E DesJardins; N Hay
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

3.  Mechanism of endogenous myc gene down-regulation in E mu-N-myc tumors.

Authors:  A Ma; R K Smith; A Tesfaye; P Achacoso; R Dildrop; N Rosenberg; F W Alt
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

Review 4.  Molecular mechanisms of cancer.

Authors:  H P Koeffler; F McCormick; C Denny
Journal:  West J Med       Date:  1991-11

5.  Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.

Authors:  A Polack; R Feederle; G Klobeck; K Hörtnagel
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.